Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for AK3280 cream evaluating safety, tolerability, and efficacy in hypertrophic scar (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar

Drugs mentioned

• AK3280 cream

Snippet

Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd. | Conditions: Hypertrophic Scar | Phase 1, Phase 2 | Status: UNKNOWN